Sontra expands SonoPrep licence pact with Bayer
This article was originally published in Clinica
Executive Summary
Sontra Medical is to gain co-exclusive worldwide rights to develop and market its SonoPrep continuous transdermal glucose monitoring system for the hospital intensive care unit market, following an amendment to a previous licensing agreement with Bayer Healthcare's diabetes care division.